Prices are well calibrated and predictably wrong in five ways: longshot bias, capital lock-up, thin books, fees, and resolution risk.Learn, CFTC, PredictionRead More

You might also be interested in reading Aclaris Therapeutics GAAP EPS of -$0.12, revenue of $1.46M.